Thermo Fisher Scientific CE Marks Oncomine Dx Target Test

CE IVD Mark brings NGS-based clinical test for solid tumors to Europe CARLSBAD, Calif., Oct. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Marking a milestone in bringing its Oncomine Dx Target Test to Europe, Thermo Fisher Scientific today ann... Diagnostics, Oncology, Regulatory Thermo Fisher Scientific, Oncomine Dx Target Test
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news